CTA-Sticky-button.png clinicaltrialsyearbook+button



    • 08:00 - 08:50
      • Registration and Refreshments

      • 08:50 - 09:00
        • Chairman's opening remarks

        • 09:00 - 09:30
          • Speaker

            Jean Barclay – Project Manager, Global Clinical Development and Regulatory Affairs, LUYE PHARMA GROUP

          Defining strategic models for data collection to ensure real time data access in databases

          • Utilising data capture systems with real time data checks to increase data quality and avoid ad hoc data entry responsibilities

          • Creating upfront data checks to add data value

          • Assessing technological advancements to aid data collection processes and reduce time consumption

          • Analysing technological risks associated with data safety to avoid security breach of collected and stored data sets

        • 09:30 - 10:00
          • Session reserved for a sponsor

            Content to be confirmed

          • 10:00 - 10:30
            • Speaker

              Daru Sharp – Early Clinical Science and Operations Lead, BRISTOL-MYERS SQUIBB

            Implementing better planning solutions to optimize data consumption

            Content to be confirmed

          • 10:30 - 11:00
            • Morning refreshments and networking

            • 11:00 - 11:30
            • Identifying easy to implement approaches for data visualization to ensure quick access to visual data set charts and maximise data potential

              • Examining the potential data quality gaps in a traditional data review approach

              • Examining how utilizing data visualization tools can help to focus resources where issues lie

              •Demonstrating how some common data review issues can be addressed more effectively utilizing visualization tools

            • 11:30 - 12:00
            • Analyzing types and categories of clinical data review by using visualization tools to minimize time consumption

              • Defining scope and gathering requirements for data review goals in the organization

              • Investigating benefits of graphical data representation compared to review of traditional tables

              • Analyzing different types and categories of clinical data review with correlated examples of graphical representations e.g. scatter and box plots for detecting outliers; line charts and shift plots for determining trends etc.

            • 12:00 - 12:30
              • Session reserved for a sponsor

                Content to be confirmed

              • 12:30 - 13:00
                • Speaker

                  Tracey Newman – Associate Director, Data Management, OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION, INC

                Achieving data integration across different data sources to shorten the clinical trial cycle and reduce costs

                Content to be confirmed

              • 13:00 - 14:30
                • Lunch and networking

                • 14:30 - 15:00
                • Implementing new technologies to increase efficiency in order to identify where to invest

                  Content to be confirmed

                • 15:00 - 15:30
                  • Session reserved for a sponsor

                  • 15:30 - 16:15
                    • Speaker

                      Charles Johnson – Associate Director, Data Management Biostatistics and Data Operations, DAIICHI SANKYO
                    • Speaker

                      Lakshmi Mallela – Principal Global Data Manager, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON&JOHNSON
                    • Speaker

                      Elsie Mathews – Director, Global Data Operations, BRISTOL-MYERS SQUIBB

                    Panel discussion: Assessing the impact of technological development on day to day data management

                    • Unravelling current trends in data management till use of technological advancements are considered

                    • Creating successful strategies to apply technological developments

                    • Addressing risks to reduce costs and ensure consistent performance

                    • Ensuring product training to optimize utilization of technology and maximize potential

                    • Investigating performance level to ensure quality throughout your trial

                  • 16:15 - 16:45
                    • Afternoon refreshments and networking

                    • 16:45 - 17:15
                      • Session reserved for a sponsor

                        Content to be confirmed

                      • 17:15 - 17:45
                        • Speaker

                          Maryam Ahmadi – Senior Director of Pharmaceutical Sciences, ACHILLION PHARMACEUTICALS, INC.

                        Developing effective relationships with CROs to optimize the standardization process and ensure timeliness are maintained

                        • Defining roles and responsibilities at the start of the clinical study environment to manage workflow streams

                        • Selecting effective collaborative platform models to manage expectations throughout a trial duration based on study type, cost, time and quality of the results

                        • Analyzing challenges associated with incorporation of standards in CROs

                        • Implementing the required level of mutual oversight and expertise to avoid lack of control and standards

                        •Taking advantage of effective relationship management to maximise performance to achieve successful application submissions

                      • 17:45 - 18:15
                        • Speaker

                          Indra Agarwal – Senior Manager, Data Management, OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC.

                        Measuring the performance of sites and CROs to ensure data quality and consistent performance are maintained

                        • Driving the successful achievement of project goals by measuring performance and productivity of sites and CROs to ensure timeliness and data quality

                        • Defining performance indicators to test standardization throughout every part of the trial

                        • Adopting a performance reporting system to ensure regular performance checks in order to maintain high standards

                        • Considering mistakes previously made at the start of your trial to minimise risks